Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer

Mitsuo Sato, Luc Girard, Ikuo Sekine, Noriaki Sunaga, Ruben D. Ramirez, Craig Kamibayashi, John D. Minna

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The underlying molecular mechanisms leading to microsatellite alteration and mutations in human lung cancer remain unknown. Since Flap endonucleasel (Fen1), which functions in the base excision repair system, has been shown to be involved in tumor progression of mouse models with microsatellite instability in a haplo-insufficient manner, we performed expression and mutation analyses for FEN1 in human lung cancer cell lines. Reverse transcriptase PCR analysis revealed that all 49 lung cancer cell lines (20 small cell lung cancers (SCLCs) and 29 non-small cell lung cancers (NSCLCs)) expressed FEN1. In addition, microarray analysis showed that FEN1 expression was elevated significantly by 1.65-fold (P = 0.001) in SCLC cell lines compared to normal lung controls (normal human lung cultures and immortalized normal human bronchial epithelial cell lines). FEN1 protein was abundantly expressed in all 23 lung cancer cell lines (10 SCLCs and 13 NSCLCs) and was expressed at lower levels in three of four normal lung epithelial culture controls. Direct sequencing of genomic DNAs revealed no FEN1 mutation in seven SCLCs and nine NSCLCs. As part of this analysis we discovered and sequenced a FEN1 pseudogene (GenBank accession #AY249897) located at 1p22.2. This pseudogene is amplified from cDNA preparations contaminated with genomic DNA and must be taken into account in any FEN1 mutation analysis studies. Our results suggest that alterations of FEN1 are not likely to contribute to development of lung cancer.

Original languageEnglish (US)
Pages (from-to)7243-7246
Number of pages4
JournalOncogene
Volume22
Issue number46
DOIs
StatePublished - Oct 16 2003

Fingerprint

Flap Endonucleases
Small Cell Lung Carcinoma
Lung Neoplasms
Cell Line
Mutation
Non-Small Cell Lung Carcinoma
Pseudogenes
Genes
Lung
Microsatellite Instability
Nucleic Acid Databases
Microarray Analysis
Reverse Transcriptase Polymerase Chain Reaction
DNA Sequence Analysis
DNA Repair
Microsatellite Repeats
Complementary DNA
Epithelial Cells
DNA
Neoplasms

Keywords

  • Base excision repair
  • Flap endonuclease 1 (FEN1)
  • Lung cancer
  • Microsatellite instability

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer. / Sato, Mitsuo; Girard, Luc; Sekine, Ikuo; Sunaga, Noriaki; Ramirez, Ruben D.; Kamibayashi, Craig; Minna, John D.

In: Oncogene, Vol. 22, No. 46, 16.10.2003, p. 7243-7246.

Research output: Contribution to journalArticle

Sato, Mitsuo ; Girard, Luc ; Sekine, Ikuo ; Sunaga, Noriaki ; Ramirez, Ruben D. ; Kamibayashi, Craig ; Minna, John D. / Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer. In: Oncogene. 2003 ; Vol. 22, No. 46. pp. 7243-7246.
@article{2e838ae73f7a4d5f8f1e254de9be63d7,
title = "Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer",
abstract = "The underlying molecular mechanisms leading to microsatellite alteration and mutations in human lung cancer remain unknown. Since Flap endonucleasel (Fen1), which functions in the base excision repair system, has been shown to be involved in tumor progression of mouse models with microsatellite instability in a haplo-insufficient manner, we performed expression and mutation analyses for FEN1 in human lung cancer cell lines. Reverse transcriptase PCR analysis revealed that all 49 lung cancer cell lines (20 small cell lung cancers (SCLCs) and 29 non-small cell lung cancers (NSCLCs)) expressed FEN1. In addition, microarray analysis showed that FEN1 expression was elevated significantly by 1.65-fold (P = 0.001) in SCLC cell lines compared to normal lung controls (normal human lung cultures and immortalized normal human bronchial epithelial cell lines). FEN1 protein was abundantly expressed in all 23 lung cancer cell lines (10 SCLCs and 13 NSCLCs) and was expressed at lower levels in three of four normal lung epithelial culture controls. Direct sequencing of genomic DNAs revealed no FEN1 mutation in seven SCLCs and nine NSCLCs. As part of this analysis we discovered and sequenced a FEN1 pseudogene (GenBank accession #AY249897) located at 1p22.2. This pseudogene is amplified from cDNA preparations contaminated with genomic DNA and must be taken into account in any FEN1 mutation analysis studies. Our results suggest that alterations of FEN1 are not likely to contribute to development of lung cancer.",
keywords = "Base excision repair, Flap endonuclease 1 (FEN1), Lung cancer, Microsatellite instability",
author = "Mitsuo Sato and Luc Girard and Ikuo Sekine and Noriaki Sunaga and Ramirez, {Ruben D.} and Craig Kamibayashi and Minna, {John D.}",
year = "2003",
month = "10",
day = "16",
doi = "10.1038/sj.onc.1206977",
language = "English (US)",
volume = "22",
pages = "7243--7246",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "46",

}

TY - JOUR

T1 - Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer

AU - Sato, Mitsuo

AU - Girard, Luc

AU - Sekine, Ikuo

AU - Sunaga, Noriaki

AU - Ramirez, Ruben D.

AU - Kamibayashi, Craig

AU - Minna, John D.

PY - 2003/10/16

Y1 - 2003/10/16

N2 - The underlying molecular mechanisms leading to microsatellite alteration and mutations in human lung cancer remain unknown. Since Flap endonucleasel (Fen1), which functions in the base excision repair system, has been shown to be involved in tumor progression of mouse models with microsatellite instability in a haplo-insufficient manner, we performed expression and mutation analyses for FEN1 in human lung cancer cell lines. Reverse transcriptase PCR analysis revealed that all 49 lung cancer cell lines (20 small cell lung cancers (SCLCs) and 29 non-small cell lung cancers (NSCLCs)) expressed FEN1. In addition, microarray analysis showed that FEN1 expression was elevated significantly by 1.65-fold (P = 0.001) in SCLC cell lines compared to normal lung controls (normal human lung cultures and immortalized normal human bronchial epithelial cell lines). FEN1 protein was abundantly expressed in all 23 lung cancer cell lines (10 SCLCs and 13 NSCLCs) and was expressed at lower levels in three of four normal lung epithelial culture controls. Direct sequencing of genomic DNAs revealed no FEN1 mutation in seven SCLCs and nine NSCLCs. As part of this analysis we discovered and sequenced a FEN1 pseudogene (GenBank accession #AY249897) located at 1p22.2. This pseudogene is amplified from cDNA preparations contaminated with genomic DNA and must be taken into account in any FEN1 mutation analysis studies. Our results suggest that alterations of FEN1 are not likely to contribute to development of lung cancer.

AB - The underlying molecular mechanisms leading to microsatellite alteration and mutations in human lung cancer remain unknown. Since Flap endonucleasel (Fen1), which functions in the base excision repair system, has been shown to be involved in tumor progression of mouse models with microsatellite instability in a haplo-insufficient manner, we performed expression and mutation analyses for FEN1 in human lung cancer cell lines. Reverse transcriptase PCR analysis revealed that all 49 lung cancer cell lines (20 small cell lung cancers (SCLCs) and 29 non-small cell lung cancers (NSCLCs)) expressed FEN1. In addition, microarray analysis showed that FEN1 expression was elevated significantly by 1.65-fold (P = 0.001) in SCLC cell lines compared to normal lung controls (normal human lung cultures and immortalized normal human bronchial epithelial cell lines). FEN1 protein was abundantly expressed in all 23 lung cancer cell lines (10 SCLCs and 13 NSCLCs) and was expressed at lower levels in three of four normal lung epithelial culture controls. Direct sequencing of genomic DNAs revealed no FEN1 mutation in seven SCLCs and nine NSCLCs. As part of this analysis we discovered and sequenced a FEN1 pseudogene (GenBank accession #AY249897) located at 1p22.2. This pseudogene is amplified from cDNA preparations contaminated with genomic DNA and must be taken into account in any FEN1 mutation analysis studies. Our results suggest that alterations of FEN1 are not likely to contribute to development of lung cancer.

KW - Base excision repair

KW - Flap endonuclease 1 (FEN1)

KW - Lung cancer

KW - Microsatellite instability

UR - http://www.scopus.com/inward/record.url?scp=0242551649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242551649&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206977

DO - 10.1038/sj.onc.1206977

M3 - Article

C2 - 14562054

AN - SCOPUS:0242551649

VL - 22

SP - 7243

EP - 7246

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 46

ER -